Drug data last refreshed 16h ago · AI intelligence enriched 1mo ago
TESULOID is a legacy injectable and oral solution product developed by Bracco, approved in 1974. The specific indication and mechanism of action are not publicly detailed in available data. This product represents a mature, established pharmaceutical asset with a narrow modern use case.
With LOE approaching and zero linked job openings, this product faces significant revenue headwinds and likely operates with a minimal, maintenance-focused team.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on TESULOID offers minimal career growth due to zero open positions and approaching loss of exclusivity. This role suits professionals seeking stability in a legacy product portfolio but offers limited advancement, skill development, or exposure to high-impact commercial initiatives.
Worked on TESULOID at Bracco? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.